Authors


Lenna Walker OD, MS, FAAO

Latest:

Case report: OCT in the detection and diagnosis of neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.


Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA

Latest:

VEW 2024: Contact Lens Institute survey reveals factors that keep patients in contact lenses

The Contact Lens Institute unveiled a preview of their data on contact lens patient retention at Vision Expo West. The full report will be released later this year.


Chris Maraboli

Latest:

Open Your Eyes documentary released on multiple platforms

Open Your Eyes documentary now available on Apple TV+ and Google Play!


Jay M. Haynie, OD, FAAO, FORS

Latest:

Victoria Conference 2023: Staying current with the AMD landscape

Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.


Noor Chahal, BS

Latest:

Study finds significant variance across imaging modalities on sizes of geographic atrophy areas

A single, consistent modality leads to better geographic atrophy tracking.


Neda Gioia, OD, CNS, FOWNS

Latest:

AAOpt 2024: What optometrists think of the NutriTears supplement so far

Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.


Rhett Schiffman, MD, MHSA

Latest:

Transcript: Visus presbyopia drop gets FDA IND OK

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application


Heidi Sutter, OD, MPH

Latest:

Lessons learned from COVID-19: How to prepare for the next public health emergency

How eye care practices and doctors can prepare for the next pandemic


Sandeep Jain

Latest:

Telehealth success hinges on better tools

As the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.


Chris Kenrick, OD

Latest:

AAOpt 2022: The importance of perioperative management in corneal crosslinking

Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.


Jamie Ho, OD, FAAO, FCOVD

Latest:

SCOPA 2022: Low vision considerations, treatments, and tools

Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."


Essence Johnson, OD, FAAO

Latest:

NOA 2023: Dissecting the state of optometry

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.


Gheorghe Necula, MD

Latest:

Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopia

An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.



Elana Meer, BA

Latest:

What the COVID-19 pandemic may mean for the power of electronic health records

Electronic health records may be the future of practice management.


Joshua Davidson, OD, FAAO, FSLS

Latest:

Agent improves near vision for irregular corneas with pinhole effect

Presbyopia-correcting drops for patients with low, up-close visual function.


Lee Vien, OD, FAAO

Latest:

How diabetes and glaucoma intersect

Consider the impact of diabetes on management of patients with glaucoma


Bernard Gilly, PhD

Latest:

Pipeline: New therapies to come for debilitating eye diseases

New drug from Gensight Biologics hits pipeline


Scott Han
Scott B. Han, OD, FAAO

Latest:

Shared care of the ocular surface before and after cataract surgery

Practices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.


Amanda Legge, OD

Latest:

Keeping an eye on geographic atrophy

How to diagnose and monitor progression.


Sheri Rowen, MD, FACS

Latest:

The Impressions and Takeaways from Patient Case No. 2

An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.


Shanell Matos

Latest:

The white cane and beyond: Part 2

Navigation and orientation technologies offer practical solution for people with vision loss.


Christina Twardowski, OD, FAAO

Latest:

AAOpt 2022: A collaborative approach to pediatric keratoconus offers positive patient outcomes

Christina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.


Flavio Mantelli, MD, PhD

Latest:

Nerve growth factor: From discovery to development for human use

The evolution opens doors for the treatment of neurotrophic keratitis and beyond.


Mitchell Jackson, MD

Latest:

ASCRS 2023: Laser scleral microporation from Ace Vision Group

Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.


Ashley Mills

Latest:

A sneak peek into the Vision Expo East 2025 show floor

Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.


Ada Noh, OD

Latest:

Biofilm busting 101

An overview of current ocular biofilm removal procedures



Shane Kannarr, OD

Latest:

Brainstorming eye care research expansion with unlimited resources

From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.


Kassi Jackson Filkins, Editor

Latest:

This week in optometry: November 13-November 17

Catch up on what happened in optometry during the week of November 13-November 17.

© 2025 MJH Life Sciences

All rights reserved.